Tsveta Milanova
CIK: 0001957180
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AGIOS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectRestricted stock units
3K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)DirectPerformance share units
3K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct8.5K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct3.3K shares at avg. $34.71$113K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct4K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $28.96$34K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct5.7K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.7K shares at avg. $28.96$49K - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectStock options (right to buy)
52K shares- - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectRestricted stock units
14K shares- - Jan 5, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct8.5K shares- - Jan 5, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct2.9K shares at avg. $27.02$78K - Dec 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct6K shares- - Dec 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct2.9K shares at avg. $27.09$79K - Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct6K shares- - Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct2.8K shares at avg. $33.54$93K - Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.7K shares at avg. $35.54$60K - Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct5.7K shares- - Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectRestricted stock units
12K shares- - Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectStock options (right to buy)
43.5K shares- - Jan 6, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct2.8K shares at avg. $32.18$90K - Jan 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct8.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Restricted stock units | 3,000 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) Performance share units | 3,000 | - | - | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 8,500 | - | $0 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 3,262 | $34.71 | $113,224 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 4,000 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,187 | $28.96 | $34,376 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 5,666 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,681 | $28.96 | $48,682 | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Stock options (right to buy) | 52,000 | - | - | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Restricted stock units | 14,000 | - | - | Direct |
| Jan 5, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 8,475 | - | $0 | Direct |
| Jan 5, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 2,872 | $27.02 | $77,601 | Direct |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 6,000 | - | $0 | Direct |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 2,932 | $27.09 | $79,428 | Direct |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 6,000 | - | - | Direct |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 2,770 | $33.54 | $92,906 | Direct |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,681 | $35.54 | $59,743 | Direct |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 5,667 | - | - | Direct |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Restricted stock units | 12,000 | - | - | Direct |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Stock options (right to buy) | 43,500 | - | - | Direct |
| Jan 6, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 2,804 | $32.18 | $90,233 | Direct |
| Jan 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 8,476 | - | $0 | Direct |
1-22 of 22 transactions
About Milanova Tsveta
Milanova Tsveta (SEC CIK 0001957180) files insider reports with the SEC as Chief Commercial Officer of AGIOS PHARMACEUTICALS, INC. (AGIO).
Signal8 holds 8 ownership filings by Milanova Tsveta, all Form 4s, filed between Jan 7, 2025 and Jun 23, 2026. Those filings report 22 transactions, from Jan 3, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Milanova Tsveta's filings is in CAMBRIDGE, MA.
Recent filings by Milanova Tsveta
- Jun 18, 2026: Grant or award of AGIO derivative securities (Form 4, code A).
- Jun 18, 2026: Option exercise of AGIO derivative securities (Form 4, code M).
- Apr 2, 2026: Option exercise of AGIO shares (Form 4, code M).
- Apr 2, 2026: Open-market sale of AGIO shares (Form 4, code S).
- Mar 2, 2026: Option exercise of AGIO shares (Form 4, code M).
Other insiders filing for AGIOS PHARMACEUTICALS, INC. (AGIO)
- Gheuens Sarah, Chief Medical Officer
- Backstrom Jay T., Director
- Ballal Rahul D., Director
- CAPELLO JEFFREY D, Director
- Foster-Cheek Kaye I, Director
- FOUSE JACQUALYN A, Director